NM_144585.4:c.1309T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_144585.4(SLC22A12):​c.1309T>C​(p.Leu437Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.227 in 1,605,460 control chromosomes in the GnomAD database, including 49,700 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L437L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.33 ( 10860 hom., cov: 33)
Exomes 𝑓: 0.22 ( 38840 hom. )

Consequence

SLC22A12
NM_144585.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.441

Publications

35 publications found
Variant links:
Genes affected
SLC22A12 (HGNC:17989): (solute carrier family 22 member 12) The protein encoded by this gene is a member of the organic anion transporter (OAT) family, and it acts as a urate transporter to regulate urate levels in blood. This protein is an integral membrane protein primarily found in epithelial cells of the proximal tubule of the kidney. An elevated level of serum urate, hyperuricemia, is associated with increased incidences of gout, and mutations in this gene cause renal hypouricemia type 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
SLC22A12 Gene-Disease associations (from GenCC):
  • hypouricemia, renal 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary renal hypouricemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 11-64600390-T-C is Benign according to our data. Variant chr11-64600390-T-C is described in ClinVar as Benign. ClinVar VariationId is 305244.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.441 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.599 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC22A12NM_144585.4 linkc.1309T>C p.Leu437Leu synonymous_variant Exon 8 of 10 ENST00000377574.6 NP_653186.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC22A12ENST00000377574.6 linkc.1309T>C p.Leu437Leu synonymous_variant Exon 8 of 10 1 NM_144585.4 ENSP00000366797.1

Frequencies

GnomAD3 genomes
AF:
0.331
AC:
50367
AN:
152034
Hom.:
10827
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.605
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.167
Gnomad EAS
AF:
0.477
Gnomad SAS
AF:
0.210
Gnomad FIN
AF:
0.298
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.289
GnomAD2 exomes
AF:
0.260
AC:
61272
AN:
236058
AF XY:
0.249
show subpopulations
Gnomad AFR exome
AF:
0.616
Gnomad AMR exome
AF:
0.240
Gnomad ASJ exome
AF:
0.173
Gnomad EAS exome
AF:
0.479
Gnomad FIN exome
AF:
0.286
Gnomad NFE exome
AF:
0.198
Gnomad OTH exome
AF:
0.245
GnomAD4 exome
AF:
0.216
AC:
314041
AN:
1453308
Hom.:
38840
Cov.:
34
AF XY:
0.214
AC XY:
154539
AN XY:
722840
show subpopulations
African (AFR)
AF:
0.617
AC:
20624
AN:
33444
American (AMR)
AF:
0.237
AC:
10456
AN:
44160
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
4557
AN:
25936
East Asian (EAS)
AF:
0.477
AC:
18898
AN:
39592
South Asian (SAS)
AF:
0.203
AC:
17288
AN:
85034
European-Finnish (FIN)
AF:
0.277
AC:
13574
AN:
49022
Middle Eastern (MID)
AF:
0.241
AC:
1387
AN:
5760
European-Non Finnish (NFE)
AF:
0.192
AC:
212755
AN:
1110202
Other (OTH)
AF:
0.241
AC:
14502
AN:
60158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
11820
23641
35461
47282
59102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7672
15344
23016
30688
38360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.332
AC:
50444
AN:
152152
Hom.:
10860
Cov.:
33
AF XY:
0.332
AC XY:
24694
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.606
AC:
25138
AN:
41516
American (AMR)
AF:
0.241
AC:
3688
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
580
AN:
3468
East Asian (EAS)
AF:
0.477
AC:
2462
AN:
5158
South Asian (SAS)
AF:
0.210
AC:
1011
AN:
4816
European-Finnish (FIN)
AF:
0.298
AC:
3162
AN:
10606
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13623
AN:
67964
Other (OTH)
AF:
0.284
AC:
601
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1539
3078
4617
6156
7695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.268
Hom.:
9954
Bravo
AF:
0.341
Asia WGS
AF:
0.350
AC:
1214
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dalmatian hypouricemia Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
5.6
DANN
Benign
0.53
PhyloP100
-0.44
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7932775; hg19: chr11-64367862; COSMIC: COSV60571815; API